215 related articles for article (PubMed ID: 21496413)
1. Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis.
Bellisai F; Morozzi G; Scaccia F; Chellini F; Simpatico A; Pecetti G; Galeazzi M
Int J Immunopathol Pharmacol; 2011; 24(1):261-4. PubMed ID: 21496413
[TBL] [Abstract][Full Text] [Related]
2. Bosentan in systemic sclerosis.
Heresi GA; Minai OA
Drugs Today (Barc); 2008 Jun; 44(6):415-28. PubMed ID: 18596996
[TBL] [Abstract][Full Text] [Related]
3. Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis.
Sfikakis PP; Papamichael C; Stamatelopoulos KS; Tousoulis D; Fragiadaki KG; Katsichti P; Stefanadis C; Mavrikakis M
Arthritis Rheum; 2007 Jun; 56(6):1985-93. PubMed ID: 17530638
[TBL] [Abstract][Full Text] [Related]
4. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
Korn JH; Mayes M; Matucci Cerinic M; Rainisio M; Pope J; Hachulla E; Rich E; Carpentier P; Molitor J; Seibold JR; Hsu V; Guillevin L; Chatterjee S; Peter HH; Coppock J; Herrick A; Merkel PA; Simms R; Denton CP; Furst D; Nguyen N; Gaitonde M; Black C
Arthritis Rheum; 2004 Dec; 50(12):3985-93. PubMed ID: 15593188
[TBL] [Abstract][Full Text] [Related]
5. The effect of bosentan on matrix metalloproteinase-9 levels in patients with systemic sclerosis-induced pulmonary hypertension.
Giannelli G; Iannone F; Marinosci F; Lapadula G; Antonaci S
Curr Med Res Opin; 2005 Mar; 21(3):327-32. PubMed ID: 15811199
[TBL] [Abstract][Full Text] [Related]
6. Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers.
Jain M; Varga J
Expert Opin Pharmacother; 2006 Aug; 7(11):1487-501. PubMed ID: 16859432
[TBL] [Abstract][Full Text] [Related]
7. [Bosentan for treatment of active digital ulcers in patients with systemic sclerosis].
Launay D; Diot E; Pasquier E; Mouthon L; Boullanger N; Fain O; Jego P; Carpentier P; Hatron PY; Hachulla E
Presse Med; 2006 Apr; 35(4 Pt 1):587-92. PubMed ID: 16614599
[TBL] [Abstract][Full Text] [Related]
8. Effect of bosentan on skin fibrosis in patients with systemic sclerosis: a prospective, open-label, non-comparative trial.
Kuhn A; Haust M; Ruland V; Weber R; Verde P; Felder G; Ohmann C; Gensch K; Ruzicka T
Rheumatology (Oxford); 2010 Jul; 49(7):1336-45. PubMed ID: 20371505
[TBL] [Abstract][Full Text] [Related]
9. Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension.
Iannone F; Riccardi MT; Guiducci S; Bizzoca R; Cinelli M; Matucci-Cerinic M; Lapadula G
Ann Rheum Dis; 2008 Aug; 67(8):1121-6. PubMed ID: 18029384
[TBL] [Abstract][Full Text] [Related]
10. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement.
Scala E; Pallotta S; Frezzolini A; Abeni D; Barbieri C; Sampogna F; De Pità O; Puddu P; Paganelli R; Russo G
Clin Exp Immunol; 2004 Dec; 138(3):540-6. PubMed ID: 15544634
[TBL] [Abstract][Full Text] [Related]
11. Bosentan improves skin perfusion of hands in patients with systemic sclerosis with pulmonary arterial hypertension.
Rosato E; Molinaro I; Borghese F; Rossi C; Pisarri S; Salsano F
J Rheumatol; 2010 Dec; 37(12):2531-9. PubMed ID: 20810512
[TBL] [Abstract][Full Text] [Related]
12. Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic Sclerosis.
Elisa T; Antonio P; Giuseppe P; Alessandro B; Giuseppe A; Federico C; Marzia D; Ruggero B; Giacomo M; Andrea O; Daniela R; Mariaelisa R; Claudio L
J Immunol Res; 2015; 2015():147616. PubMed ID: 26090478
[TBL] [Abstract][Full Text] [Related]
13. Bosentan treatment for Raynauds phenomenon and skin fibrosis in patients with Systemic Sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study.
Giordano N; Puccetti L; Papakostas P; Di Pietra N; Bruni F; Pasqui AL; Acampa M; Bocchi V; Donati V; Voglino M; Fioravanti A; Montella A; Auteri A; Nuti R; Pastorelli M
Int J Immunopathol Pharmacol; 2010; 23(4):1185-94. PubMed ID: 21244767
[TBL] [Abstract][Full Text] [Related]
14. Gastric Juice Expression of Th-17 and T-Reg Related Cytokines in Scleroderma Esophageal Involvement.
Nicola S; Rolla G; Bucca C; Geronazzo G; Ridolfi I; Ferraris A; Fusaro E; Peroni CL; Dughera L; Brussino L
Cells; 2020 Sep; 9(9):. PubMed ID: 32947843
[TBL] [Abstract][Full Text] [Related]
15. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.
Antonelli A; Fallahi P; Ferrari SM; Giuggioli D; Colaci M; Di Domenicantonio A; Ferri C
J Rheumatol; 2012 May; 39(5):979-85. PubMed ID: 22422499
[TBL] [Abstract][Full Text] [Related]
16. Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility.
Penn H; Quillinan N; Khan K; Chakravarty K; Ong VH; Burns A; Denton CP
QJM; 2013 Sep; 106(9):839-48. PubMed ID: 23696678
[TBL] [Abstract][Full Text] [Related]
17. Bosentan for digital ulcers in patients with systemic sclerosis.
Nagai Y; Hasegawa M; Hattori T; Okada E; Tago O; Ishikawa O
J Dermatol; 2012 Jan; 39(1):48-51. PubMed ID: 21955007
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)].
Riccardi MT; Chialà A; Lannone F; Grattagliano V; Covelli M; Lapadula G
Reumatismo; 2007; 59(2):135-9. PubMed ID: 17603693
[TBL] [Abstract][Full Text] [Related]
19. Bosentan: a review of its use in the management of digital ulcers associated with systemic sclerosis.
Dhillon S
Drugs; 2009 Oct; 69(14):2005-24. PubMed ID: 19747014
[TBL] [Abstract][Full Text] [Related]
20. IL-17, IL-6 and IFN-γ in Systemic Sclerosis Patients.
Bălănescu P; Lădaru A; Bălănescu E; Nicolau A; Băicuş C; Dan GA
Rom J Intern Med; 2015; 53(1):44-9. PubMed ID: 26076560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
